Several years ago, an outbreak of the Bluetongue virus (BTV) in The Netherlands caused disease, paralysis, deformed offspring and death of sheep and cattle. The economic damage amounted to tens of millions of euros. It is only a matter of time before the next outbreak must be faced.
A more effective vaccine
Wageningen Bioveterinary Research developed an innovative prototype vaccine against Bluetongue, which is expected to be more effective than vaccines that are currently available.
Furthermore, the new vaccine can be easily adapted to new virus strains. This would mean this disease can be controlled more rapidly.